Respipure Pharma Private Limited

Respipure Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN U24290MH2022PTC375528 Incorporated 27 January 2022 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹45.41 Lakh
▲ 1202.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹5.5 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹77.43 Cr
Secured borrowings
Company age
4 yrs
Est. 2022
Last financials
Mar 2025
Balance sheet date

About Respipure Pharma Private Limited

Data last updated: 07 March 2026

Respipure Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Trihal Pharma Private Limited. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 27 January 2022.

Registered with ROC Mumbai under CIN U24290MH2022PTC375528.

Capital: an authorised share capital of ₹5.5 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Shekhar Shrawankumar Bhuwania and Manish Shah Mangilal.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Shop – 75 Floor – 7Th Plot – 215 Free Press House Free Press Journal Marg Nariman Point, Mumbai, Maharashtra, India – 400021.

As per the financials filed for FY 2025, the company reported a revenue of ₹45.41 Lakh, reflecting significant growth compared to the previous year.

It operates as a subsidiary of Trihal Pharma Private Limited.

As per MCA filings, the company has open charges of ₹77.43 Cr on record.

Company Details of Respipure Pharma Private Limited
CIN U24290MH2022PTC375528
Registration Number 375528
Incorporation Date 27 January 2022
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Trihal Pharma Private Limited
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Shop – 75 Floor – 7Th Plot – 215 Free Press House Free Press Journal Marg Nariman Point, Mumbai, Maharashtra, India – 400021
  • Industry
    Pharma, Drug Formulation & Development
Company report
Respipure Pharma Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Respipure Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Respipure Pharma Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Business Activity of Respipure Pharma Private Limited

Respipure Pharma Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including manufacture of chemicals and chemical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing 20 Manufacture of chemicals and chemical products Locked
Premium access

Business activity turnover details for Respipure Pharma Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Respipure Pharma Private Limited

Respipure Pharma Private Limited is audited by VANITA BHUVA & CO for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
VANITA BHUVA & CO Locked Locked Locked
Premium access

Complete auditor history for Respipure Pharma Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Respipure Pharma Private Limited

Respipure Pharma Private Limited is currently managed by 3 directors, with 1 former director having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Shekhar Shrawankumar Bhuwania Director 15 Jun 2022 4 Years 1 Months Current
Manish Shah Mangilal Director 27 Jan 2022 4 Years 6 Months Current
Nishant Vaish Director 27 Jan 2022 4 Years 6 Months Current

Financials of Respipure Pharma Private Limited FY 2025 filings available

Respipure Pharma Private Limited reported revenue of ₹45.41 Lakh (up 1202.00% YoY) for FY 2025.

Revenue · FY 2025
₹45.41 Lakh ▲ 1202.00%
Premium access

Ten-year financial statements for Respipure Pharma Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Respipure Pharma Private Limited

Premium access

Shareholding and ownership data for Respipure Pharma Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Respipure Pharma Private Limited

Open charges
₹77.43 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Hdfc Bank Limited₹77.43 Cr
Latest charge details
DateLenderAmountStatus
30 Apr 2025 Hdfc Bank Limited ₹15 Lakh Open
18 Oct 2023 Hdfc Bank Limited ₹38.64 Cr Open
19 Dec 2022 Hdfc Bank Limited ₹38.64 Cr Open

Total charge records: 3 View all charges

Employees and EPFO Compliance at Respipure Pharma Private Limited

Respipure Pharma Private Limited has a workforce of 0 employees as of Mar 25, 2024.

Active EPFO establishments
1
Premium access

Employee and EPFO history for Respipure Pharma Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Respipure Pharma Private Limited

Premium access

GST registrations and filing compliance for Respipure Pharma Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Respipure Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Respipure Pharma Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Respipure Pharma Private Limited

Premium access

MSME payment history for Respipure Pharma Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Respipure Pharma Private Limited

Premium access

Corporate group structure for Respipure Pharma Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Respipure Pharma Private Limited

Premium access

MCA filings and documents for Respipure Pharma Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Respipure Pharma Private Limited

Activity
30 Sep 2025
Respipure Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
26 Aug 2025
A charge with Hdfc Bank Limited of Rs. 38.64 Cr registered on 18 Oct 2023 with Charge ID 100806250 was modified on 26 Aug 2025.
Charges
30 Apr 2025
A charge with Hdfc Bank Limited amounted to Rs. 0.15 Cr with Charge ID 101109538 was registered on 30 Apr 2025.
Activity
31 Mar 2025
Respipure Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
05 Jul 2024
A charge with Hdfc Bank Limited of Rs. 38.64 Cr registered on 19 Dec 2022 with Charge ID 100657340 was modified on 05 Jul 2024.
Charges
18 Oct 2023
A charge with Hdfc Bank Limited amounted to Rs. 38.64 Cr with Charge ID 100806250 was registered on 18 Oct 2023.

Frequently Asked Questions about Respipure Pharma Private Limited

Respipure Pharma Private Limited is an active private limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 27 January 2022 (4+ years old) and is registered under CIN U24290MH2022PTC375528.

Respipure Pharma Private Limited reported revenue of ₹45.41 Lakh for FY 2025 (up 1202.00% YoY).

The current directors of Respipure Pharma Private Limited are:

The primary industry of Respipure Pharma Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Respipure Pharma Private Limited can be reached at the registered office: Shop – 75 Floor – 7Th Plot – 215 Free Press House Free Press Journal Marg Nariman Point, Mumbai, Maharashtra, India – 400021.

The authorised capital is ₹5.5 Cr, and the paid-up capital is ₹1 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available